These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1926868)

  • 41. Function of heparin.
    RILEY JF; SHEPHERD DM; WEST GB; STROUD SW
    Nature; 1955 Dec; 176(4493):1123. PubMed ID: 13272756
    [No Abstract]   [Full Text] [Related]  

  • 42. Commentary on heparin-like glycosaminoglycans.
    Conrad E
    Angiogenesis; 1997; 1(1):16-9. PubMed ID: 14517387
    [No Abstract]   [Full Text] [Related]  

  • 43. Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
    Hirafuji M; Nezu A; Shinoda H; Minami M
    Br J Pharmacol; 1996 Jan; 117(2):299-304. PubMed ID: 8789382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Updating on in-vivo and in-vitro effects of heparin and other glycosaminoglycans (mesoglycan) on arterial endothelium: a morphometrical study.
    Tanganelli P; Bianciardi G; Carducci A; Palummo N; Simoes C; Tarabochia B; Weber G; Verzuri MS; Auteri A
    Int J Tissue React; 1992; 14(3):149-53. PubMed ID: 1446979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation by basic fibroblast growth factor of glycosaminoglycan biosynthesis in cultured vascular endothelial cells.
    Kaji T; Hiraga S; Ohkawara S; Inada M; Yamamoto C; Kozuka H; Koizumi F
    Microvasc Res; 1995 May; 49(3):268-76. PubMed ID: 7643748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans.
    Majack RA; Clowes AW
    J Cell Physiol; 1984 Mar; 118(3):253-6. PubMed ID: 6699099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thromboresistance of the arterial wall: the role of heparin and glycosaminoglycans.
    Bianciardi G; Frigidi E; Palummo N; Simoes C; Tanganelli P; Weber G
    Wien Klin Wochenschr; 1991; 103(14):412-5. PubMed ID: 1926868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of vascular smooth muscle cell growth by heparin and heparan sulfates.
    Castellot JJ; Wright TC; Karnovsky MJ
    Semin Thromb Hemost; 1987 Oct; 13(4):489-503. PubMed ID: 2827311
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arterial wall-determined risk factors to vascular diseases: a nonhuman primate model.
    Wang XL; Wang J; Shi Q; Carey KD; VandeBerg JL
    Cell Biochem Biophys; 2004; 40(3):371-88. PubMed ID: 15211033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelial cell influences on vascular smooth muscle phenotype.
    Campbell JH; Campbell GR
    Annu Rev Physiol; 1986; 48():295-306. PubMed ID: 3518616
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.